Quick Takeaways
- Kenneth Galbraith has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,031,379.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Kenneth Galbraith
- Location
- Surrey, British Columbia, Canada
- Summary
- The estimated net worth of Kenneth Galbraith is at least $8,031,379 dollars as of 12 Jan 2026. Kenneth Galbraith is the Chair & CEO, Director of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $8.01M. Kenneth Galbraith is the Director of MACROGENICS INC and owns shares of MACROGENICS INC (MGNX) stock worth about $22.6K.
- Signature
- /s/ Daniel Dex, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kenneth Galbraith and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Zymeworks Inc. ($8,008,729).
- Past-year value change for that position: -$3,337,971.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kenneth Galbraith
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | Chair & CEO, Director | $8,008,729 | -$3,337,971 | -29% | 12 Jan 2026 |
| MGNX | MACROGENICS INC | Director | $22,650 | 13 May 2021 | ||
| ZYME | Zymeworks Inc. | Chair, President & CEO, Director | 15 Jan 2022 |
Insider Transactions Reported by Kenneth Galbraith:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.